TriGuard Embolic Protection Device in percutaneous cardiac interventions with intracavitary cardiac thrombosis: A case series.

Autor: Marcon L; Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino, IRCCS, Milan, Italy., Sicuso R; Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino, IRCCS, Milan, Italy., Galli S; Department of Interventional Cardiology, Centro Cardiologico Monzino, IRCCS, Milano, Italy., Majocchi B; Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino, IRCCS, Milan, Italy., Carbucicchio C; Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino, IRCCS, Milan, Italy., Tondo C; Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino, IRCCS, Milan, Italy., Fassini GM; Cardiac Arrhythmia Research Centre, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Jazyk: angličtina
Zdroj: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2024 Jan; Vol. 47 (1), pp. 106-112. Date of Electronic Publication: 2023 May 19.
DOI: 10.1111/pace.14712
Abstrakt: Embolic cerebral protection devices are not routinely used in clinical practice during electrophysiological interventions. We report a case series of patients with intracardiac thrombosis undergoing a percutaneous left atrial appendage (LAA) closure and a ventricular tachycardia (VT) catheter ablation supported by TriGuard 3 Cerebral Embolic Protection Device.
(© 2023 The Authors. Pacing and Clinical Electrophysiology published by Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: